Linked Life Data

9934474

Source:http://linkedlifedata.com/resource/pubmed/id/9934474

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
24
pubmed:dateCreated
1999-4-5
pubmed:abstractText
A new series of cysLT1 receptor antagonists represented by CP-288,886 (7) and CP-265,298 (8) were developed which are equipotent to clinical cysLT1 receptor antagonists Zafirlukast (1) and Pranlukast (2).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0960-894X
pubmed:author
pubmed:issnType
Print
pubmed:day
15
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3577-82
pubmed:dateRevised
2004-12-3
pubmed:meshHeading
pubmed:year
1998
pubmed:articleTitle
Development of 2,2-dimethylchromanol cysteinyl LT1 receptor antagonists.
pubmed:affiliation
Central Research Division, Pfizer Inc., Groton, CT 06340, USA.
pubmed:publicationType
Journal Article